Evaluation of Comfort Using Olopatadine Hydrochloride 0.1% Ophthalmic Solution in the Treatment of Allergic Conjunctivitis in Contact Lens Wearers Compared to Placebo Using the Conjunctival Allergen-Challenge Model

Phase 3 Randomized Double-Masked Study of Efficacy and Safety of Once-Daily 0.77% Olopatadine Hydrochloride Ophthalmic Solution in Subjects With Allergic Conjunctivitis Using the Conjunctival Allergen Challenge Model

Cornea ◽

10.1097/ico.0000000000000562 ◽

2015 ◽

Vol 34 (10) ◽

pp. 1245-1251 ◽

Cited By ~ 7

Author(s):

Eugene McLaurin ◽

Abhijit Narvekar ◽

Paul Gomes ◽

Adeniyi Adewale ◽

Gail Torkildsen

Keyword(s):

Allergic Conjunctivitis ◽

Allergen Challenge ◽

Ophthalmic Solution ◽

Efficacy And Safety ◽

Phase 3 ◽

Once Daily ◽

An Evaluation of Onset and Duration of Action of Patanol® (Olopatadine Hydrochloride Ophthalmic Solution 0.1%) Compared to Claritin® (Loratadine 10 mg) Tablets in Acute Allergic Conjunctivitis in the Conjunctival Allergen Challenge Model

Acta Ophthalmologica Scandinavica ◽

10.1034/j.1600-0420.2000.078s230060.x ◽

2000 ◽

Vol 78 ◽

pp. 60-63 ◽

Cited By ~ 40

Author(s):

Mark B. Abelson ◽

Donna L. Welch

Keyword(s):

Allergic Conjunctivitis ◽

Allergen Challenge ◽

Ophthalmic Solution ◽

Duration Of Action ◽

Emedastine ophthalmic solution 0.05% versus levocabastine ophthalmic suspension 0.05% in the treatment of allergic conjunctivitis using the conjunctival allergen challenge model

American Journal of Ophthalmology ◽

10.1016/s0002-9394(00)00689-9 ◽

2000 ◽

Vol 130 (6) ◽

pp. 717-723 ◽

Cited By ~ 18

Author(s):

Peter A Netland ◽

Charles Leahy ◽

Kathleen L Krenzer

Keyword(s):

Allergic Conjunctivitis ◽

Allergen Challenge ◽

Ophthalmic Solution ◽

Ophthalmic Suspension

Bioequivalence of two formulations of ketotifen fumarate ophthalmic solution: A single-center, randomized, double-masked conjunctival allergen challenge investigation in allergic conjunctivitis

Clinical Therapeutics ◽

10.1016/s0149-2918(08)80051-3 ◽

2008 ◽

Vol 30 (7) ◽

pp. 1272-1282 ◽

Cited By ~ 10

Author(s):

Gail L. Torkildsen ◽

Mark B. Abelson ◽

Paul J. Gomes

Keyword(s):

Allergic Conjunctivitis ◽

Allergen Challenge ◽

Ophthalmic Solution ◽

Single Center ◽

Ketotifen Fumarate ◽

Conjunctival Allergen Challenge

Comparison of the clinical efficacy and comfort of olopatadine hydrochloride 0.1% ophthalmic solution and nedocromil sodium 2% ophthalmic solution in the human conjunctival allergen challenge model

Clinical Therapeutics ◽

10.1016/s0149-2918(00)83044-1 ◽

2000 ◽

Vol 22 (12) ◽

pp. 1462-1472 ◽

Cited By ~ 36

Author(s):

Salim Butrus ◽

Jack V. Greiner ◽

Marino Discepola ◽

Ira Finegold

Keyword(s):

Clinical Efficacy ◽

Allergen Challenge ◽

Ophthalmic Solution ◽

Nedocromil Sodium ◽

364 Zero Itch in Eyes Treated With Olopatadine Hydrochloride Ophthalmic Solution, 0.2% in Bilateral Conjunctival Allergen Challenge Studies

World Allergy Organization Journal ◽

10.1097/01.wox.0000412127.79639.64 ◽

2012 ◽

Vol 5 ◽

pp. S116-S117

Author(s):

Michael S. Blaiss ◽

Maria Tort

Keyword(s):

Allergen Challenge ◽

Ophthalmic Solution ◽

A comparison of the clinical efficacy of pheniramine maleate/naphazoline hydrochloride ophthalmic solution and olopatadine hydrochloride ophthalmic solution in the conjunctival allergen challenge model

Clinical Therapeutics ◽

10.1016/j.clinthera.2005.04.011 ◽

2005 ◽

Vol 27 (5) ◽

pp. 568-577 ◽

Cited By ~ 17

Author(s):

Jack V. Greiner ◽

Ira J. Udell

Keyword(s):

Clinical Efficacy ◽

Allergen Challenge ◽

Ophthalmic Solution ◽

Pheniramine Maleate ◽

Phase III trials examining the efficacy of cetirizine ophthalmic solution 0.24% compared to vehicle for the treatment of allergic conjunctivitis in the conjunctival allergen challenge model

Clinical Ophthalmology ◽

10.2147/opth.s185835 ◽

2018 ◽

Vol Volume 12 ◽

pp. 2617-2628 ◽

Cited By ~ 4

Author(s):

Edward Meier ◽

Gail Torkildsen ◽

Paul Gomes ◽

Mark C. Jasek

Keyword(s):

Allergic Conjunctivitis ◽

Allergen Challenge ◽

Ophthalmic Solution ◽

Phase Iii ◽

Phase Iii Trials ◽

Conjunctival Allergen Challenge

Efficacy and safety of olopatadine hydrochloride 0.77% in patients with allergic conjunctivitis using a conjunctival allergen-challenge model

Clinical Ophthalmology ◽

10.2147/opth.s83263 ◽

2015 ◽

pp. 1703 ◽

Cited By ~ 10

Author(s):

Gail Torkildsen ◽

Abhijit Narvekar ◽

Mark Bergmann

Keyword(s):

Allergic Conjunctivitis ◽

Allergen Challenge ◽

Efficacy And Safety ◽

Efficacy and Safety Of a New Olopatadine Hydrochloride, 0.77% Ophthalmic Formulation In Patients With Allergic Conjunctivitis Using The Conjunctival Allergen Challenge (CAC) Model (NCT01479374)

Journal of Allergy and Clinical Immunology ◽

10.1016/j.jaci.2013.12.982 ◽

2014 ◽

Vol 133 (2) ◽

pp. AB277

Author(s):

Gail Torkildsen ◽

Thomas Macejko ◽

Abhijit Narvekar ◽

Mark Bergmann

Keyword(s):

Allergic Conjunctivitis ◽

Allergen Challenge ◽

Efficacy And Safety ◽

Ophthalmic Formulation ◽